These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 32702599)

  • 41. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
    Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
    Front Immunol; 2019; 10():6. PubMed ID: 30761122
    [No Abstract]   [Full Text] [Related]  

  • 42. Expression and function of CXC and CC chemokines in human malignant liver tumors: a role for human monokine induced by gamma-interferon in lymphocyte recruitment to hepatocellular carcinoma.
    Yoong KF; Afford SC; Jones R; Aujla P; Qin S; Price K; Hubscher SG; Adams DH
    Hepatology; 1999 Jul; 30(1):100-11. PubMed ID: 10385645
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The therapeutic candidate for immune checkpoint inhibitors elucidated by the status of tumor-infiltrating lymphocytes (TILs) and programmed death ligand 1 (PD-L1) expression in triple negative breast cancer (TNBC).
    Tomioka N; Azuma M; Ikarashi M; Yamamoto M; Sato M; Watanabe KI; Yamashiro K; Takahashi M
    Breast Cancer; 2018 Jan; 25(1):34-42. PubMed ID: 28488168
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of Annexins.
    Gou R; Zhu L; Zheng M; Guo Q; Hu Y; Li X; Liu J; Lin B
    J Transl Med; 2019 Sep; 17(1):275. PubMed ID: 31474227
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Magnetic resonance imaging and molecular features associated with tumor-infiltrating lymphocytes in breast cancer.
    Wu J; Li X; Teng X; Rubin DL; Napel S; Daniel BL; Li R
    Breast Cancer Res; 2018 Sep; 20(1):101. PubMed ID: 30176944
    [TBL] [Abstract][Full Text] [Related]  

  • 46. DAB2IP Plays Important Clinical Significance and Correlates With Immune Infiltration in Renal Cell Carcinoma.
    Cao H; Zhang J; Wang W
    Technol Cancer Res Treat; 2020; 19():1533033820936682. PubMed ID: 32583730
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tumour-infiltrating lymphocytes (TILs) and BRCA-like status in stage III breast cancer patients randomised to adjuvant intensified platinum-based chemotherapy versus conventional chemotherapy.
    de Boo L; Cimino-Mathews A; Lubeck Y; Daletzakis A; Opdam M; Sanders J; Hooijberg E; van Rossum A; Loncova Z; Rieder D; Trajanoski Z; Vollebergh M; Sobral-Leite M; van de Vijver K; Broeks A; van der Wiel R; van Tinteren H; Linn S; Horlings HM; Kok M
    Eur J Cancer; 2020 Mar; 127():240-250. PubMed ID: 31956037
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Abundant tumor infiltrating lymphocytes after primary systemic chemotherapy predicts poor prognosis in estrogen receptor-positive/HER2-negative breast cancers.
    Watanabe T; Hida AI; Inoue N; Imamura M; Fujimoto Y; Akazawa K; Hirota S; Miyoshi Y
    Breast Cancer Res Treat; 2018 Feb; 168(1):135-145. PubMed ID: 29168063
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of the Chemokine Receptor CXCR3 Correlates with Dendritic Cell Recruitment and Prognosis in Gastric Cancer.
    Chen F; Yin S; Niu L; Luo J; Wang B; Xu Z; Yang G
    Genet Test Mol Biomarkers; 2018 Jan; 22(1):35-42. PubMed ID: 29266971
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Coexpression of PBX1 and EMP2 as Prognostic Biomarkers in Estrogen Receptor-Negative Breast Cancer via Data Mining.
    Qiu Y; Lu G; Wu Y
    J Comput Biol; 2020 Oct; 27(10):1509-1518. PubMed ID: 32216630
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High methionyl-tRNA synthetase expression predicts poor prognosis in patients with breast cancer.
    Jin Q; Liu G; Wang B; Li S; Ni K; Wang C; Ren J; Zhang S; Dai Y
    J Clin Pathol; 2020 Dec; 73(12):803-812. PubMed ID: 32404475
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of LCN1 as a Potential Biomarker for Breast Cancer by Bioinformatic Analysis.
    Yang Y; Li F; Luo X; Jia B; Zhao X; Liu B; Gao R; Yang L; Wei W; He J
    DNA Cell Biol; 2019 Oct; 38(10):1088-1099. PubMed ID: 31424267
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic values of F-box members in breast cancer: an online database analysis and literature review.
    Wang X; Zhang T; Zhang S; Shan J
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30341246
    [No Abstract]   [Full Text] [Related]  

  • 54. Integrative Analysis of the Expression Levels and Prognostic Values for NEK Family Members in Breast Cancer.
    Gao WL; Niu L; Chen WL; Zhang YQ; Huang WH
    Front Genet; 2022; 13():798170. PubMed ID: 35368696
    [No Abstract]   [Full Text] [Related]  

  • 55. Identification of prognostic biomarkers among ICAMs in the breast cancer microenvironment.
    Chen H; Pu S; Mei N; Liu X; He J; Zhang H
    Cancer Biomark; 2022; 35(4):379-393. PubMed ID: 36373309
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ki67 and lymphocytes in the pretherapeutic core biopsy of primary invasive breast cancer: positive markers of therapy response prediction and superior survival.
    Schlotter CM; Tietze L; Vogt U; Heinsen CV; Hahn A
    Horm Mol Biol Clin Investig; 2017 Sep; 32(2):. PubMed ID: 28937963
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of Prognostic Biomarkers and Molecular Targets Among JAK Family in Breast Cancer.
    Liu F; Wu H
    J Inflamm Res; 2021; 14():97-114. PubMed ID: 33469338
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Selective infiltration of CCR5(+)CXCR3(+) T lymphocytes in human colorectal carcinoma.
    Musha H; Ohtani H; Mizoi T; Kinouchi M; Nakayama T; Shiiba K; Miyagawa K; Nagura H; Yoshie O; Sasaki I
    Int J Cancer; 2005 Oct; 116(6):949-56. PubMed ID: 15856455
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Overexpressed Pseudogene
    Lyu L; Yao J; Wang M; Zheng Y; Xu P; Wang S; Zhang D; Deng Y; Wu Y; Yang S; Lyu J; Guan F; Dai Z
    Front Oncol; 2020; 10():1245. PubMed ID: 32903535
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PLOD2 Is a Potent Prognostic Marker and Associates with Immune Infiltration in Cervical Cancer.
    Li G; Wang X; Liu G
    Biomed Res Int; 2021; 2021():5512340. PubMed ID: 34258263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.